We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Solving the 3D Structure of Zika Virus NS1 May Aid in Vaccine Development

By LabMedica International staff writers
Posted on 10 Aug 2016
A team of molecular virologists has established the crystal structure of the full-length Zika virus NS1 (nonstructural protein 1), a critical virulence protein that functions in genome replication and host immune-system modulation.

Investigators at the University of Michigan (Ann Arbor, USA) and Purdue University (West Lafayette, IN, USA) had previously isolated and mapped the NS1 protein from dengue and West Nile viruses. More...
In the current study, they used X-ray crystallography and electron microscopy to generate the three-dimensional molecular structure of the Zika virus NS1.

They reported in the July 25, 2016, online edition of the journal Nature Structural & Molecular Biology that while the Zika NS1 was similar to that of other related viruses, the Zika NS1 structure had a few important differences. One departure from the structure of dengue NS1 was the positioning of flexible loops on the wing domains of the protein.

“From NS1 structure studies in dengue, it was thought this loop flipped up, but our study in Zika virus shows it flips down from the wings,” said contributing author Dr. Richard Kuhn, professor of biological sciences at Purdue University. “This is very important because it indicates an interaction with the cellular membrane of the host and a possible mechanism by which NS1 carries out its multiple functions.”

In addition, the outer surface of the Zika NS1 protein had substantially different electrical-charge properties than those of other flaviviruses, which suggested that it may interact differently with components of an infected person’s immune system.

“Having the structure of the full-length Zika NS1 provides new information that can help guide the design of a potential vaccine or antiviral drugs,” said senior author Dr. Janet Smith, professor of biological chemistry at the University of Michigan. “Researchers are still working to understand precisely how Zika and other flaviviruses interact with an infected person’s immune system. Having these atomic-level details can help scientists to ask better questions and to design more thoughtful experiments as we continue to learn new information.”

Related Links:
University of Michigan
Purdue University

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.